Source: International Congress 2014 – Airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Tzilogianni, P. Bakakos, A. I. Papaioannou, A. Papaporfyriou, G. Hillas, S. Papiris, N. Koulouris, S. Loukides, K. Kostikas (Athens, Greece). Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control. Eur Respir J 2014; 44: Suppl. 58, 1001

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review Source: International Congress 2014 – Airway biomarkers Year: 2014 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Urinary LTE4 may be associated with TH2-driven asthma: Initial data from the Pan-European U-BIOPRED IMI project Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Influence of psychological characteristics of patients for asthma control Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Asthma control is not related to large airways function Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Sputum neutrophil differential cell count in health and relationship to disease severity in asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 The effects of oral care on FeNO measurement in asthmatic patients Source: International Congress 2014 – Airway biomarkers Year: 2014 The course and outcomes of pregnancy in women with bronchial asthma Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016